You are here
-
Home
- Events
Biobank breakthroughs - a lecture by Professor Sir Rory Collins FRS
- Date
- 17.06.25
- Start time
- 12:30
- End time
- 13:30
- Where
- Online (Zoom)
This is a members-only event. This event may not be available to all members, so please check with the organiser before you apply to become a member.
Log in or register to make a booking
A lecture on the UK Biobank: scale, depth, duration… but, most importantly, accessibility
Talk outline
UK Biobank is a prospective cohort study of 500,000 people aged 40-60 when recruited in 2006-10 that integrates large-scale genomic data (including sequencing) and deep phenotyping data (including lifestyle factors, physical measures and multi-modal imaging) with long-term longitudinal health records. The recent addition of large-scale metabolomic and proteomic data is creating an even more powerful resource, enabling better understanding of disease biology and discovery of novel drug targets.
With its unique combination of scale, depth, duration and accessibility, UK Biobank is enabling tens of thousands of researchers worldwide to perform innovative cardiovascular discovery science. This talk will provide information about UK Biobank, highlight recent enhancements for studying particular conditions, and describe its cloud-based Research Analysis Platform that further democratises secure research access.
About our speaker
Rory Collins is a medically-qualified epidemiologist who studies how to prevent and treat cardiovascular disease in large international population-based studies. He is the founding Head of Oxford University's Nuffield Department of Population Health.
During the past 40 years, he has conducted large randomised trials which have shown unequivocally that clot-dissolving and clot-preventing treatments during a heart attack can more than halve mortality, and that lowering LDL-cholesterol with statin therapy safely reduces the risk of cardiovascular death and disability among a wide range of people. As a consequence, these treatments are being widely used.
In 2005, the Wellcome Trust and Medical Research Council appointed him as Principal Investigator and Chief Executive of UK Biobank. Involving 500,000 participants, it is the largest deeply-characterized prospective study globally, available for any type of health research that is in the public interest. More than 30,000 researchers worldwide use it currently, generating more than 3000 papers in 2023 alone.
Chair
This webinar will be chaired by the RSB President-elect, Professor Dame Melanie Welham DBE FRSB
Who should attend?
This talk would be of interest to scientists, students, and those interested in the progression of the UK Biobank.
Cost and booking
This event is free to attend and exclusively for RSB members (including paid membership applications awaiting election on 1 July). Spaces are limited so advance registration is essential through the link at the top of the page.
Special requirements
If you have accessibility requirements, please let us know during your booking using the additional information options, and we will do what we can to accommodate your needs.
Continuing Professional Development
This event is approved by the Royal Society of Biology for the purposes of CPD and can be counted as 3 CPD points.